Rafferty Asset Management, LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1389426
New York, NY
Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,104,335
-$1,348,811 QoQ
Shares Held
126,132
-18.6% QoQ
Ownership
0.109%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rafferty Asset Management, LLC holds $408,627,656 across 136 Biotechnology names. VKTX ranks #41 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
54,572 | $24,368,580 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
29,589 | $22,861,644 | |
| 3 | INSM |
INSMED Inc
|
116,069 | $18,979,602 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
50,553 | $16,726,471 | |
| 5 | APLS |
Apellis Pharmaceuticals, Inc.
|
180,471 | $7,260,348 | |
| 6 | MRNA |
Moderna, Inc.
|
114,194 | $5,801,055 | |
| 7 | INCY |
Incyte Corp
|
60,565 | $5,700,377 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
10,452 | $5,471,308 |
All Filings in VKTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,104,335 | 126,132 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,453,146 | 155,007 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,239,890 | 199,387 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,173,723 | 157,499 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,438,021 | 183,769 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $10,911,599 | 271,163 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $16,065,102 | 253,753 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $17,788,353 | 335,566 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $10,475,992 | 127,756 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,691,103 | 413,278 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $6,201,192 | 560,180 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,549,542 | 342,353 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,996,194 | 540,312 | Shares | Sole | 2023-05-11 | |
| 2021-12-31 | $1,053,947 | 229,119 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $825,217 | 131,404 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $1,110,761 | 185,436 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,200,910 | 347,970 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $315,482 | 56,036 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $888,364 | 152,640 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $378,416 | 52,485 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $67,078 | 14,333 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||